Table 3 Medications of all patients at baseline—responders and non-responders
From: Galectin-3 predicts response and outcomes after cardiac resynchronization therapy
All (N = 61) | Responders (N = 49) | Non-responders (N = 12) | p* | |
|---|---|---|---|---|
ß-blockers | 55 (90%) | 45 (92%) | 10 (83%) | 0.40 |
ACE or ARB | 61 (100%) | 49 (100%) | 12 (100%) | – |
MRA | 43 (70%) | 36 (73%) | 7 (58%) | 0.31 |
Diuretics | 46 (75%) | 37 (76%) | 9 (76%) | 0.97 |
Anticoagulant | 6 (10%) | 5 (10%) | 1 (8%) | 0.84 |
Antiplatelet therapy | 38 (62%) | 20 (41%) | 9 (75%) | 0.30 |